Skip to main content

Dorothy Flower

Partner and Head of Medical & Life Sciences

Get in touch

Dorothy is one of the UK’s leading medical malpractice lawyers. She regularly defends private sector organisations and individuals in clinical negligence cases, acts for manufacturers and suppliers of medical devices and pharmaceuticals involved in product liability claims, and defends CROs involved in injury claims in connection with clinical trials. The regulatory side to her practice sees Dorothy assisting individuals investigated by the General Medical Council, Health and Care Professions Council and other regulatory bodies. She also advises organisations on Care Quality Commission regulation.

 “My team and I not only get brilliant results, we're personable and fun to work with”

“I've acted in numerous cross-jurisdictional and multi-jurisdiction claims, representing both US and UK clients.  I have overseen the defence of large claims globally to ensure uniform strategy.  

I am hugely knowledgeable and experienced, and get to the important aspects of any matter quickly and early to provide far-sighted strategic advice. I am creative in strategic thinking and robust in my approach to litigation. I fight to get the client the best possible commercial, personal, and legal outcomes.

I aim to know my clients personally, in the context of both work and social events.  I am proud that my team is approachable, efficient, and responsive 24/7, and will go to great lengths for the client.”

Dorothy’s recent work highlights:

Acting for Spire Healthcare in the inquests into the deaths of up to 100 patients of Ian Paterson for breast surgery, coupled with management of the Paterson Patients Compensation Fund. 

Acted for Corin Limited in metal-on-metal hip group litigation in the UK, and managing the defence of claims against Corin in Europe, Australia, Japan, and Canada. 

Acting for a London cosmetic surgery clinic in claims arising from the negligent performance of cosmetic procedures and the inappropriate conduct of a surgeon.

Stay connected and subscribe to our latest insights and views 

Subscribe Here